EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Drug-eluting contact lenses: Progress, challenges, and prospects

Dongdong Gao, Chunxiao Yan iD, Yong Wang iD, Heqing Yang, Mengxin Liu, Yi Wang, Chunmei Li iD, Chao Li iD, Gang Cheng, Lijun Zhang iD

Biointerphases · 2024

DOI: 10.1116/6.0003612 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biointerphases, 2024. Verfasst von Dongdong Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116033, China. Hauptthemen laut MEDLINE: Contact Lenses, Drug Delivery Systems, Ophthalmic Solutions. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science Research Project Of The Third People's Hospital Of Dalian, Dalian Science and Technology Innovation Fund, Department of Science and Technology of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topical ophthalmic solutions (eye drops) are becoming increasingly popular in treating and preventing ocular diseases for their safety, noninvasiveness, and ease of handling. However, the static and dynamic barriers of eyes cause the extremely low bioavailability (<5%) of eye drops, making ocular therapy challenging. Thus, drug-eluting corneal contact lenses (DECLs) have been intensively investigated as a drug delivery device for their attractive properties, such as sustained drug release and improved bioavailability. In order to promote the clinical application of DECLs, multiple aspects, i.e., drug release and penetration, safety, and biocompatibility, of these drug delivery systems were thoroughly examined. In this review, we systematically discussed advances in DECLs, including types of preparation materials, drug-loading strategies, drug release mechanisms, strategies for penetrating ocular barriers, in vitro and in vivo drug delivery and penetration detection, safety, and biocompatibility validation methods, as well as challenges and future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contact LensesDrug Delivery SystemsOphthalmic SolutionsHumansAnimalsCorneaBiological Availability

Substanzen

Ophthalmic Solutions

Autor:innen und Institutionen

  • Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116033, China.
  • School of Engineering, Westlake University, Hangzhou, Zhejiang 310030, China.
  • The Third People's Hospital of Dalian, Liaoning Provincial Key Laboratory of Cornea and Ocular Surface Diseases, Liaoning Provincial Optometry Technology Engineering Research Center, Dalian, Liaoning 116033, China.
  • Department of Pharmaceutical Sciences, State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China.
  • Tsinglan School, Songshan Lake, Dongguan 523000, China.

ORCID-Profile: Chunxiao Yan, Yong Wang, Chunmei Li, Chao Li, Lijun Zhang

Förderung

  • The Science Research Project Of The Third People's Hospital Of Dalian
  • Dalian Science and Technology Innovation Fund
  • Department of Science and Technology of Liaoning Province
  • National Natural Science Foundation of China

Zitieren

APA

Gao, D., Yan, C., Wang, Y., Yang, H., Liu, M., Wang, Y., Li, C., Li, C., Cheng, G., & Zhang, L. (2024). Drug-eluting contact lenses: Progress, challenges, and prospects. Biointerphases. https://doi.org/10.1116/6.0003612

Vancouver

Gao D, Yan C, Wang Y, Yang H, Liu M, Wang Y, et al. Drug-eluting contact lenses: Progress, challenges, and prospects. Biointerphases. 2024. doi:10.1116/6.0003612

BibTeX
@article{Gao2024,
  author = {Gao, Dongdong and Yan, Chunxiao and Wang, Yong and Yang, Heqing and Liu, Mengxin and Wang, Yi and Li, Chunmei and Li, Chao and Cheng, Gang and Zhang, Lijun},
  title = {Drug-eluting contact lenses: Progress, challenges, and prospects},
  journal = {Biointerphases},
  year = {2024},
  doi = {10.1116/6.0003612}
}
Kostenlos starten →